Literature DB >> 29245111

Community-based rehabilitation offers cost-effective epilepsy treatment in rural Guinea-Bissau.

Eric van Diessen1, Frank van der Maas2, Vladimir Cabral2, Willem M Otte3.   

Abstract

Treatment of epilepsy in low-income countries is a challenge considering the lack of resources, availability of antiepileptic drugs, and cultural beliefs. We used a community-based rehabilitation (CBR) service for the detection, monitoring, and treatment of epilepsy. A local network of trained community volunteers provided education, good quality antiepileptic drugs, and clinical follow-up for people with epilepsy (PWE). In a period of 2years, approximately 22,500 people were screened in central Guinea-Bissau, and 112 PWE were identified and registered. Monthly check-ups were offered to monitor treatment effect and increase compliance. Retrospective analysis on 81 records of patients under treatment in June 2016 showed a decrease of seizure frequency in 88.8% after treatment initiation and was maintained throughout the clinical follow-up of 15months. A conservative estimation of the treatment and monitoring of a single person with epilepsy revealed a daily cost of $0.73. Despite acknowledging epilepsy as a neglected condition by the World Health Organization (WHO), most PWE still lack appropriate treatment. Although CBR service has been suggested as efficient strategy to reduce the treatment gap, little information is available on the efficacy of the programs. Our experiences show that CBR service is a cost-effective approach to monitor treatment and increase compliance in PWE. This experience may be of value for other resource-poor settings.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epilepsy; Global health; Low-cost; Outreach program; Phenobarbital; Resource-poor setting; Sub-Saharan Africa

Mesh:

Substances:

Year:  2017        PMID: 29245111     DOI: 10.1016/j.yebeh.2017.11.009

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  10 in total

Review 1.  Global Health and Epilepsy: Update and Future Directions.

Authors:  Mary C Spiciarich; Jane R von Gaudecker; Laura Jurasek; Dave F Clarke; Jorge Burneo; Jorge Vidaurre
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-01       Impact factor: 5.081

2.  Impact of poorly controlled epilepsy in the Republic of Guinea.

Authors:  Minyoung Jang; Foksouna Sakadi; Nana R Tassiou; Cissé F Abass; Sara J Grundy; Arcer Woga; Bah A Kenda; Condé M Lamine; Balde A Talibé; Hongxiang Qiu; Joseph M Cohen; Marco Carone; Farrah J Mateen
Journal:  Seizure       Date:  2018-07-24       Impact factor: 3.184

3.  Economic Burden of Epilepsy in Rural Ituri, Democratic Republic of Congo.

Authors:  Joseph Nelson Siewe Fodjo; Michel Mandro; Deogratias Wonya'rossi; Yasemine Inaç; Francoise Ngave; Richard Lokonda; Aimé Anyolito; Frederik Verelst; Robert Colebunders
Journal:  EClinicalMedicine       Date:  2019-03-27

4.  Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin.

Authors:  Joseph Nelson Siewe Fodjo; Godwin Tatah; Earnest Njih Tabah; Leonard Ngarka; Leonard Njamnshi Nfor; Samuel Eric Chokote; Michel K Mengnjo; Fidèle Dema; Aurélien Tele Sitouok; Grace Nkoro; Félicien E Ntone; Anne-Cécile Zoung-Kanyi Bissek; Cédric B Chesnais; Michel Boussinesq; Robert Colebunders; Alfred K Njamnshi
Journal:  Infect Dis Poverty       Date:  2018-12-03       Impact factor: 4.520

Review 5.  Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys.

Authors:  Joseph Nelson Siewe Fodjo; Marieke C J Dekker; Richard Idro; Michel Ndahura Mandro; Pierre-Marie Preux; Alfred K Njamnshi; Robert Colebunders
Journal:  Infect Dis Poverty       Date:  2019-02-10       Impact factor: 4.520

Review 6.  Dietary Flavonoids Interaction with CREB-BDNF Pathway: An Unconventional Approach for Comprehensive Management of Epilepsy.

Authors:  Pallavi Sharma; Amit Kumar; Damanpreet Singh
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

7.  Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.

Authors:  Michel Mandro; Joseph Nelson Siewe Fodjo; Deby Mukendi; Alfred Dusabimana; Sonia Menon; Steven Haesendonckx; Richard Lokonda; Swabra Nakato; Francoise Nyisi; Germain Abhafule; Deogratias Wonya'Rossi; Jean Marie Jakwong; Patrick Suykerbuyk; Jacques Meganck; An Hotterbeekx; Robert Colebunders
Journal:  PLoS Negl Trop Dis       Date:  2020-01-10

8.  Community health workers to improve adherence to anti-seizure medication in rural South Africa: Is it cost-effective?

Authors:  Ryan G Wagner; Fredrik Norström; Melanie Y Bertram; Stephen Tollman; Lars Forsgren; Charles R Newton; Lars Lindholm
Journal:  Epilepsia       Date:  2020-11-25       Impact factor: 5.864

9.  Community perceptions and attitudes regarding epilepsy and disease cost after implementation of a community-based epilepsy treatment program in onchocerciasis-endemic communities in the Democratic Republic of Congo.

Authors:  Alfred Dusabimana; Michel Ndahura Mandro; Joseph Nelson Siewe Fodjo; Husseini Dolo; Samuel Coenen; Robert Colebunders
Journal:  Epilepsy Behav       Date:  2021-01-27       Impact factor: 2.937

Review 10.  Is patient navigation a solution to the problem of "leaving no one behind"? A scoping review of evidence from low-income countries.

Authors:  Sarah Louart; Emmanuel Bonnet; Valéry Ridde
Journal:  Health Policy Plan       Date:  2021-03-03       Impact factor: 3.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.